Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial-Reference-Cited by-同舟云学术

Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial

Published:2018-04 Issue: Volume:257 Page:102-107
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Cavallari Ilaria,Ruff Christian T.,Nordio Francesco,Deenadayalu Naveen,Shi Minggao,Lanz Hans,Rutman Howard,Mercuri Michele F.,Antman Elliott M.,Braunwald Eugene,Giugliano Robert P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Warfarin discontinuation after starting warfarin for atrial fibrillation;Fang;Circ. Cardiovasc. Qual. Outcomes,2010

2. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann. Intern. Med.,2007

3. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence;Genewein;Br. J. Haematol.,1996

4. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants—a prospective study;Palareti;Thromb. Haemost.,1994

5. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N. Engl. J. Med.,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF;Journal of the American Heart Association;2024-09-03

2. Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation;JAMA Cardiology;2024-09-01

3. Fine-needle aspiration cytology for neck lesions in patients with antithrombotic/anticoagulant medications: systematic review and meta-analysis;European Radiology;2024-03-27

4. Evaluating the effect of inequalities in oral anti-coagulant prescribing on outcomes in people with atrial fibrillation;European Heart Journal Open;2024-03-01

5. Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation;Thrombosis Research;2023-10